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Purpose. Efficacy of cultivated oral mucosa epithelial transplantation (COMET) procedure in corneal epithelium restoration of
aniridia patients.Methods. Study subjects were aniridia patients (13 patients; 17 eyes) with irregular, vascular conjunctival pannus
involving visual axis who underwent autologous transplantation of cultivated epithelium. For the procedure oral mucosa epithelial
cells were obtained from buccal mucosa with further enzymatic treatment. Suspension of single cells was seeded on previously
prepared denuded amniotic membrane. Cultures were carried on culture dishes inserts in the presence of the inactivated with
Mitomycin Cmonolayer of 3T3 fibroblasts. Cultures were carried for seven days. Stratified oral mucosa epitheliumwith its amniotic
membrane carrier was transplanted on the surgically denuded corneal surface of aniridia patients with total or subtotal limbal stem
cell deficiency.Outcome Measures. Corneal surface, epithelial regularity, and visual acuity improvement were evaluated. Results. At
the end of the observation period, 76.4% of the eyes had regular transparent epithelium and 23.5% had developed epithelial defects
or central corneal haze; in 88.2% of cases visual acuity had increased. VA range was from HM 0.05 before the surgery to HM up to
0.1 after surgery. Conclusion. Application of cultivated oral mucosa epithelium restores regular epithelium on the corneal surface
with moderate improvement in quality of vision.
1. Introduction
During second decade of life, aniridic patients begin devel-
oping pathologic cellular exchange. Epithelial cells covering
the cornea are removed by the surrounding conjunctival
epithelium with its vascularized matrix [1]. This leads to a
local disorder called limbal stem-cell deficiency (LSCD) [2].
Its stages lead to superficial conjunctival ingrowth, corneal
haze, discomfort, and deep loss of visual acuity. Since
the 1980s, the concept of limbal disease management has
focused on limbal transplantation and removal of pathologic
tissue followed by transplantation of autologous or allogeneic
limbal tissue carried on the donor’s sclera [3, 4]. Many
studies have confirmed that delivery of healthy limbal tissue
improves vision and decreases ocular discomfort [5–7].
Development of new culture techniques has changed
the treatment of LSCD [8]. Transplantation became limited
to cultured autologous cells, without additional tissues of
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the donor’s sclera or conjunctiva [9]. Application of oral
mucosa epithelium was proposed by Shigeru Kinoshita and
was turned into clinical practice by Nakamura et al. [10].
Another new concept was use of oral mucosa epithelium in
reconstruction of the ocular surface [11]. With a phenotype
similar to the cornea, it allowed the possibility of autologous
treatment in patients with bilateral ocular involvement [12].
Congenital aniridia is a rare disorder of autosomal-
dominant or sporadic occurrence. It occurs with an incidence
of slightly less than 1 : 100,000 to 1 : 60,000 in the general
population. It manifests with low visual acuity and ambly-
opia early. Later it usually is accompanied by cataract and
glaucoma. From the second decade of life, an additional
factor influences visual quality: corneal haze caused by the
conjunctivalization of the cornea surface [13].
In aniridia patients, signs of LSCD are ocular discom-
fort, superficial vascular conjunctival pannus, and decreased
visual acuity. Severity is mild; therefore, for several years
those patients were disqualified from any surgery. Cultivated
oral mucosa epithelium transplantation (COMET) offers
minimal and effective surgical approach for this group of
patients.
2. Materials and Methods
The experimental procedure was performed under the tenets
of the Declaration of Helsinki. Signed written informed
consent was obtained from all patients before the procedure
began.
Oral mucosa epithelium specimens (3–5mm2) were
collected under local anesthesia and decontaminated with
5% povidone-iodine solution. Biopsies were taken from the
inferior buccal mucosa; no sutures were applied. The tissue
was transferred immediately to corneal storage medium at
4∘C and then taken to the laboratory.
The tissue specimenwas treatedwithDispase II for 1 hour,
after which it was trypsinized with 1% trypsin/0.01% EDTA
mixture for 10min in 37∘C to obtain a single cell suspension.
Epithelial cells were prepared for seeding with a density of
4 × 104 cells per 1mL (Cell counter, Coulter Z1,Miami,USA).
Culturemedia and chemicals were purchased from Sigma
(Germany). The reagents for immunostaining were obtained
from Santa Cruz Biotechnology Inc. (USA). The epithelial
culture was carried in the presence of 3T3 fibroblasts, a source
of growth factors. Oneweek prior to specimen collection, six-
well culture dishes (Becton Dickinson, USA) were prepared.
Bottoms of the plates were covered with a monolayer of
3T3 fibroblasts (ATCC, USA). The 3T3 cells were cultivated
in Dulbecco Modified Eagle’s Medium (DMEM) with 10%
bovine serum and a 100 𝜇g/mL penicillin and streptomycin
mixture. From the fifth to seventh day of culture, when
the monolayer was reached, fibroblasts were inactivated by
incubation inDMEMcontaining 2𝜇g/mLofMitomycinC for
2 h.
The carrier for the oral mucosa epithelial sheet was
the amniotic membrane located on the dish insert over
the monolayer of fibroblasts. Amniotic membrane carriers
were obtained from the Homograft Tissue Bank in Zabrze,
Figure 1: Cultivated oral epithelium (E) on the amniotic membrane
(A) prior to transplantation. H&E stain. Scale bar: 20 𝜇m.
Poland. Amniotic membrane samples were washed from
the cryoprotective medium with Phosphate Buffered Saline
(PBS), and the amniotic epithelium was removed gently with
a culture scraper. Denuded amniotic membrane slides (15 ×
15mm) on nitrocellulose paper were put over the layer of
fibroblasts in the culture plates.
Single oral mucosa cells were seeded on denuded amni-
otic membrane spread on nitrocellulose paper lying on
the inserts over the fibroblast monolayer. Cultures were
carried out in standard conditions of 37∘C and a humidified
atmosphere of 5% CO
2
and 95% air. The medium was a
supplemented Dulbecco Modified Eagle’s Medium (DMEM)
with HAM F12 mixture with 10% of serum (bovine serum
in first 12 experiments, autologous serum in the next 5
cultures), 0.5% dimethyl sulfoxide (DMSO), 10 ng/mLmouse
Epidermal Growth Factor (EGF), 5 𝜇g/mL bovine insulin,
0.1 nM cholera toxin, 0.18mM adenine, 2 nM triiodothyro-
nine, 4mM L-glutamine, 0.4mg/mL hydrocortisone, and
100 𝜇g/mL penicillin and streptomycin mixture. The culture
medium was changed every 48 h. Cultures were carried out
on at least 2 amniotic membranes for each patient. On
the seventh day of culture, the epithelial growth stage was
evaluated under light microscope and small specimens of
each membrane (Figure 1) were stained with hematoxylin-
eosin (H-E). Amniotic membranes (A in Figure 1) covered
completely with multilayer epithelium (E in Figure 1) were
suitable for a graft. Cultivation over 7 days caused loss
of superficial cells of the proliferating epithelium to the
medium. At the time of microscopic qualification, airlifting
was done. Cells were airlifted with a minimal amount of
culture medium for 1 h.
One day before the transplantation, immunostaining for
cytokeratin 4, cytokeratin 13, protein p63, and connexin 43
was performed to confirm the origin of the epithelium and
identify the presence of low differentiated cells. Both cytok-
eratins 4 and 13 were described by Ang et al. as characteristic
for oral mucosa epithelial cells, their presence confirming
expected cellular structure of the graft just before application
[14]. Protein p63 (transcription factor) plays an important
role in epithelial cells proliferation and differentiation, in
cultured cells it shows cellular potential for epithelial renewal
[15]. Gap-junction protein connexin 43 is present in the
basal epithelial layer, and positive staining confirms proper
architecture of cultured epithelial layers [16]. Hematoxylin-
eosin (H-E) staining was used in histological analysis of
epithelial layer regularity and thickness. Regular structure
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of intact epithelium on amniotic membrane presented on
Figure 1 was expected by researchers. Only such grafts were
qualified in surgery.
Study subjects were 13 aniridia patients (17 eyes) suffering
from LSCD with central corneal involvement. Vascular con-
junctival pannus involved the entire limbal area (total LSCD:
14 eyes) or at least 9 clock-hours of the limbus with central
involvement (subtotal LSCD: 3 eyes).Themain indication for
the study was presence of semitransparent conjunctival pan-
nus covering the cornea over the pupil. It caused decreased
quality of vision even in cases of subtotal limbal involvement.
The patients were both oral mucosa epithelium donors and
recipients of the cultured epithelium. There were 3 men and
10women. Ages ranged from 16 to 54with an average of 31.1±
11.5 years. In 4 cases, surgery was bilateral and sequential
(3–6 months between each surgery). Visual acuity before
intervention ranged fromHM to 0.05. Inclusion criteria were
congenital aniridia, conjunctivalization of the corneal surface
with neovascularization (with or without corneal scarring)
and at least 6 months from last eye surgery. In addition,
the study required healthy oral mucosa, no smoking for at
least 7 days before taking a sample of epithelium, and regular
teeth brushing (twice a day). Exclusion criteria were acute
systemic infections, acute eye infection during the last 6
months, neoplasm history, pregnancy, and mental disorders.
In addition patients with dense cataract coexisting corneal
disorders were excluded.
Surgerywas performedunder topical anesthesia (Alcaine,
Alcon, USA). A 360-degree peritomy was done, followed by
conjunctival suturing at 1-2mm behind the limbal area with
single 10-0 nylon sutures. The conjunctival pannus was
removed gently with a spatula or crescent knife. If necessary,
fibrotic tissue spread under the conjunctival pannus was
removed with gentle keratectomy to prepare a smooth cor-
neal surface. Then, round, 14mm diameter trephined amni-
otic carriers with oral mucosa epithelial cells were trans-
planted onto the denuded corneas. Peripheral, continuous
10-0 nylon suture was used to stabilize the graft. The entire
cornea was covered, and suture was placed in the corneolim-
bal interface.Then, the graftwas covered by a bandage contact
lens.
After the procedure, levofloxacin (Santen, Finland) and
preservative-free dexamethasone eye drops (Thea Laborato-
ries, Paris, France) were administered 5 times a day for 2
weeks. Then, dexamethasone alone was applied 3 times a day
for 6 weeks. All subjects received preservative-free lubricants
every 2 hours, and in cases of epithelial defects or erosions,
autologous serum drops were administered. On each con-
trol visit, stabilization of the corneal surface was evaluated
with topical 10% fluorescein staining. Lack of epithelial
defects (negative fluorescein staining) with regular, stratified
epithelium or no more than 3 clock-hours of peripheral
conjunctival neovascularization was classified as a successful
case (coded as +++); partial success consisted of punctate
epithelial defects or peripheral conjunctival neovasculariza-
tion up to 9 clock-hours without pupil area involvement
(coded as ++); and failure consisted of vascularization of
the pupil area, persistent nonhealing epithelial defects or

























Figure 2: Cumulative graft survival: Kaplan-Meier curve for
COMET in aniridia.
occurrence was total or subtotal made no differences in
surgical management or postoperative treatment regarding
360-degree peritomy and removal of all fibrotic tissue or
epithelia from the corneal surface.
3. Results
Local complications were not seen after oral mucosa dona-
tion. Transplanted specimens showed regular, stratified
epithelium of 4–9 layers of cells. Epithelium origin was
confirmed by previous immunostaining, as described in the
culture procedure section.
Over the observation period of 12–18months, 13 operated
eyes showed stable epithelium; however, peripheral vascular
irregularities were present in all of them. Table 1 shows
detailed patient data. These corneas were not stained by
fluorescein solution (qualified as +++); 4 eyes suffered various
epithelial defects, from single local defects (++) to large areas
of denuded cornea (+)with peripheral conjunctival ingrowth.
At the end of the observation period, 3 eyes developed
stromal scarring, conjunctival vascularization, or stromal
vascularization. All 3 of these eyes were qualified as graft
failure. In successful cases, the epithelium was smooth and
regular (qualified as +++ and ++). Figure 2 presents the graft
survival rate on a Kaplan-Meier curve. The first 9 postop-
erative months were critical to the final results. Occurrence
of epithelial defect was the indication for autologous serum
eye drops. Despite careful treatment, 3 failed cases developed
after 6 months of progressive invasion of the central cornea
by vascular conjunctival tissue. In other cases, the periph-
eral area was characterized by irregularities in the vascular
network, with peripheral ingrowth of new vessels without
central area involvement. Comparison of surfaces before and
after surgery (Figures 3(a) and 3(b)) shows improvement of
corneal transparency in the central area and irregular distri-
bution of vessels in the limbal area. Inflammatory response,
defined as hyperemia and neovascularization at the donor-
host interface, was moderate and easily controlled with a
steroid agent. Limited vascular ingrowth in eyes with stable
autologous oral epithelium confirms that COMET with its
autologous origin limits inflammatory response.There is also
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Table 1: Overview of aniridia patients data.
Case Age Gender Eye BCVApre
BCVA
post Epithelial regularity Follow-up (m.) Treatment
1 28 F R CF 0.05 +++ 18 Routine
2 28 F L 0.05 0.1 +++ 12 Routine
3 27 F R 0.02 0.1 +++ 14 Routine
4 54 F R HM CF + 13 Routine, PSED, DEX
5 26 F L 0.02 0.05 +++ 18 Routine
6 29 F R 0.05 0.05 +++ 18 Routine
7 27 F L 0.01 0.03 + 17 Routine, PSED, DEX
8 18 F L HM 0.1 +++ 18 Routine
9 18 F R HM 0.05 +++ 14 Routine
10 49 M L CF 0.1 +++ 18 Routine
11 40 F R CF 0.05 +++ 15 Routine, TSED
12 23 M L HM CF +++ 18 Routine, TSED
13 38 F L 0.01 0.02 +++ 18 Routine
14 38 F R HM 0.05 ++ 15 Routine, PSED
15 49 M L CF 0.1 +++ 12 Routine
16 16 F L HM HM +++ 18 Routine, TSED
17 22 F R HM 0.05 + 16 Routine, PSED, DEX
Fluorescein staining: absent (+++), local defects (++), and present (+).
CF: counting fingers and HM: hand movements.
Routine treatment: Levofloxacin and dexamethasone eye drops 5 times a day for a 2-week period and then only dexamethasone 3 times a day for the next 6
weeks.
Additional treatment: PSED: permanent serum eye drops, TSED: temporary serum eye drops, and DEX: additional dexamethasone administration over 2nd
month from surgery.
(a) (b)
Figure 3: (a) and (b) Aniridia patient, 49-year-old man, who underwent cataract surgery 5 years before COMET. Preoperative view with
central fibrovascular scar on the left; on the right, 6 months after surgery, VA improvement from CF to 0.1 with central cornea covered by
regular and smooth epithelium.
no immune reaction characteristic for allotransplantation in,
for example, keratolimbal allografts (KLAL). Excluding the
failed grafts, patients noted improvement in their quality of
vision, as well as decreased ocular discomfort. Postoperative
occurrence of epithelial defects did not interfere with visual
acuity and were treated with autologous serum drops 7 times
a day. Four eyes with epithelial defects received persistent
therapy; in three others (graded as +++) therapy was tem-
porary for up to four weeks. Visual acuity improvement was
noted in 88.2% of cases. It ranged from HM up to 0.1. As
shown in Figure 3 main benefit of COMET was restoring
of transparent epithelium without pathologic vessels on the
corneal surface.This 49-year-old, single-eyedman developed
conjunctival pannus after cataract surgery performed 5 years
ago. Improvement to 0.1 restored his ability to read; he
pointed it as a main benefit of surgery. Despite moderate
improvement of VA the majority of patients were satisfied
after surgery.
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4. Discussion
LSCD is a difficult therapeutic challenge in patients with con-
genital aniridia. This condition is mild in severity and is
usually accompanied by amblyopia, cataracts, and corneal
haze caused by conjunctival pannus. It is believed that pro-
gressive conjunctivalization with age is connected to congen-
ital impairment of pluripotent cells located in the hem.
In 2003, Nakamura and Kinoshita proposed a cultivation
method of oral epithelium to restore ocular epithelial surface
based on experiments on rabbits [17]. Several benefits made
the procedure very interesting. Damaged corneas covered
by autologous epithelium have a lower risk of immunologic
reaction. Oral epithelium transplanted onto the new locus
can maintain its proliferative potential without developing
keratinization. In addition, low differentiation and quick
cellular turnover result in regular stratified epithelium.
An important factor of this method is the cellular phe-
notype of oral epithelium. The phenotype is similar to the
corneal epithelium phenotype, making this procedure safe
and easy to apply. Allografts often require systemic or local
immunosuppressive agents administered for long periods
postoperatively. Autografts do not have such requirements,
as the induction of neovascularization is lower if the tissue
comes from the same patient [18].
As described by Hata et al., oral epithelium culture is very
effective for recipients, as these cells have a low stage of dif-
ferentiation combined with fast cellular turnover [19]. To
obtain a regular epithelial layer, only a few days of culturing
are needed. In addition, these features are prolonged for the
postoperative period. In long-term observation, it improves
stability of the transplanted epithelium. In our patients, the
surface epithelium in successful cases remained stable with
temporary epithelial disorders. In local defects, autologous
serum drops were administered to improve epithelial growth.
For large defects autologous serum or bandage contact
lenses were ineffective. Such patients in our study developed
secondary conjunctival ingrowth leading to failure of the
procedure.
COMET is widely proposed in Stevens-Johnson Syn-
drome (SJS), ocular cicatricial pemphigoid (OCP) and ocular
burns. However, in those cases many patients require 2-
step surgical approach to restore vision due to accompanied
stromal damage. Sotozono et al. describes such cases showing
that long-term visual improvement is possible even with
high rate of postoperative epithelial defects (40%) [20]. In
acute cases of SJS or OCP damage of the ocular surface
and inflammation grade is high. Authors have only one
case of aniridia and a few cases with slight ocular surface
damage. In those cases visual improvement is significantly
high. In aniridic patients ocular surface disease is limited to
the epithelial surface and subepithelial fibrosis. There is no
severe inflammation or destruction of surrounding tissues.
In our group there was also no need of stromal procedures
of lamellar or penetrating keratoplasty. Final vision remained
low; however, main benefit was stable epithelial surface with
only 3 failed grafts and 4 patients with epithelial defects (3
of them were temporary). If compared to severe cases of
ocular surface disease in aniridia there was no indication to
administration of systemic steroids.
Historically, therapeutic treatment has included Scheffer
Tseng’s approach of removing the corneal pannus com-
bined with lamellar keratoplasty or penetrating keratoplasty
combined with limbal allotransplantation. However, allo-
transplants require subsequent systemic immunosuppres-
sion, which can interfere with the patient’s general health.
Complicity and difficulty of the technique resulted in the
need to transplant only those epithelial cells involved in the
pathologic process. COMET offered the opportunity to focus
on the affected area of the corneal surface.
Tsubota et al. describing keratolimbal allografts shows
high risk of immune adverse reactions (graft rejection),
infections, and systemic disorders associated with immuno-
suppressive agents administered for many postoperative
months [21]. In his study stable ocular surface in achieved
in 51% of the cases. If we compare improvements in vision,
allografts limit the quality of vision [22]. Risk of rejection
and revascularization result in loss of visual acuity in long-
term observations. The Kaplan-Meier curves for the allograft
approach show continuous reduction of success rate in the
long term. Daya et al. reports results of allogeneic cultured
corneal epithelium transplantation with success rate of 70%
[23]. It indicates that limitation of surgical approach to
epithelial surface only increases success rate. Nishida et al.
report 100% success rate after COMET; however, in other
studies authors achieve stabilization of corneal surface in
66.7% or even 57.5% [24–26]. The autologous approach
with oral epithelium transplantation seems to cause less
immunization, less inflammatory response, and less vascular
ingrowth. These benefits should increase the success rate in
bilateral limbal stem-cell insufficiency present in aniridia.
There were not many differences between culture pro-
cedures for the oral and corneal epithelium transplantation
techniques. Amniotic membrane substrate as a cellular car-
rier and the source of basement membrane is widely applied
[27, 28]. Its efficacy is confirmed in papers on cultured
epithelial transplantation. Amniotic membrane makes the
application of oral epithelial sheets safe and easy. Inmild cases
with partial limbal insufficiency in aniridia, transplantation
limited to the application of amniotic membrane can support
the corneal epithelium for a long period of time. Coculture
with 3T3 fibroblasts results in fast proliferation andmaintains
low differentiation of the oral epithelium. This parameter
is crucial for graft survival, despite fast cellular turnover.
Another advantage is the almost unlimited source of tissue,
which can be collected easily. The regenerative potential of
oral epithelium is high. During cultivation, loss of superficial
epithelial cells to the media was observed after seven days. In
our opinion, a culture period of oneweek is sufficient to reach
stable oral epithelial multilayers.
In 2003, Nakamura et al. described the first oral epithe-
lium transplantations in humans with corneas severely dam-
aged by Stevens-Johnson Syndrome (SJS) and severe ocular
burns. Results were promising, and oral epithelium became
a substitute for corneal epithelium with satisfactory corneal
transparency and reduction of ocular discomfort. Nakamura
et al. later described 17 patients treated with the COMET
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procedure with a mean follow-up of 55 months [29]. All
eyes manifested revascularization of the surface with various
stages of severity. The most stable epithelia were observed
within six months after surgery. Visual acuity improvement
was observed in 95% of patients after surgery. After 36
months, only 53% of eyes noted improved visual acuity. The
authors concluded that despite the decrease in vision quality,
the reconjunctivalization was less severe than that before
surgery. In failed cases presented in the paper, conjunctival
invasion was not severe; however, involvement of visual axis
caused failure of the entire treatment.
Another paper on COMET by Ang et al. described stabi-
lization of the ocular surface without major complications in
all investigated eyes for at least 12 months after surgery [14].
Graft survival was limited in COMET; however, scarification
of the ocular surface was much less severe compared with
untreated patients. In addition, combining COMET with
penetrating keratoplasty led to improved ocular surface and
decreased risk of PK failure [30].
Satake presented the results of 40 eyes after COMET. Pro-
cedure were performed on SJS, cicatricial pemphigoid, and
ocular burn patients [26]. Results showed the fast decline of
graft survival in the first six months after the procedures with
subsequent stabilization. Outcomes depended on the severity
of ocular involvement; patients with severe vascularization
and damage to the cornea surface were at greater risk of early
graft failure than those with less severe symptoms. Similarly,
poor primary visual acuity resulted in a worse outcome for
those in the aniridia group. However, analysis has not been
performed on patients with congenital aniridia. According to
our study, graft survival and epithelium regularity are much
better in aniridia patients.
Visual acuity in patients with aniridia depends on the
optical transparency of both the cornea and the lens. In 75%
of patients, cataracts occurred next to the corneal pannus,
which greatly affected visual acuity.Therefore, in our opinion,
visual acuity is a poor success parameter of transplant-
cultured oral mucosal epithelium. In the success group
graded +++, there were eyes with no visual acuity improve-
ment despite a stable surface, showing that other factors,
such as foveal hypoplasia, optic nerve lesions, or cataracts,
were disturbing vision. In our study, the criterion for success
was restoration of the corneal epithelium, although it is
known that the most important criterion for patients is visual
acuity. Increased corneal vascularization with patient age is
associated with epithelial cell dysfunction, but the exact cause
has not been documented clearly yet. Some authors make
effective use of anti-VEGF, but the literature does not describe
the use of anti-VEGF in corneal neovascularization.
Application of COMET was successful in aniridia
patients.The visual acuity improvement rate for aniridia cases
was lower than that for SJS, ocular cicatricial pemphigoid, or
ocular burn cases. While actual visual acuity improvement
was lower, the main benefit was improvement of epithelial
regularity. Chen et al. investigated cell survival in COMET
patients [31]. The majority of recipients in the follow-up had
oral mucosa-derived cells The present study has confirmed
the usefulness of the procedure in cases of mild limbal
insufficiencies, such as in aniridia patients. In conclusion,
COMET is a very useful surgical procedure for patients with
congenital aniridia, as it delivers benefits withminimal harm.
Further studies are needed to compare epithelium restoring
procedures including etiology of limbal stem deficiency.
Summary Statement
COMET procedure is a minimal invasive treatment, which
enable exchanging irregular corneal epithelium for regular
stratified oral mucosa epithelium. Aniridia causes huge dis-
comfort; COMET not only restores stable ocular surface but
also improves quality of life. Another advantage is simple
surgical approach, autologous transplantation, and nonag-
gressive postoperative treatment. Visual acuity improvement
is more efficient for near than for far distance; the majority of
patients were able to read again.
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